Dr. Ambati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-8171
Education & Training
- Memorial Sloan Kettering Cancer CenterPost-Doctoral Fellowship, 2012 - 2014
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2009 - 2012
- Nicklaus Children's HospitalResidency, Pediatrics, 2006 - 2009
- Banaras Hindu University IOMClass of 2002
Certifications & Licensure
- NY State Medical License 2011 - 2026
- UT State Medical License 2009 - 2012
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 3 citationsComplete responses to odronextamab in two patients with diffuse large B-cell lymphoma refractory to chimeric antigen receptor T-cell therapy.Matt Weinstock, Pavania Elavalakanar, Susan Bright, Srikanth R Ambati, Jurriaan Brouwer-Visser
British Journal of Haematology. 2022-11-01 - 90 citationsOdronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymp...Rajat Bannerji, Jon E Arnason, Ranjana H Advani, Jennifer R Brown, John N Allan
The Lancet. Haematology. 2022-05-01 - 679 citationsExtracellular Vesicle and Particle Biomarkers Define Multiple Human CancersAyuko Hoshino, Han Sang Kim, Linda Bojmar, Kofi Ennu Gyan, Michele Cioffi
Cell. 2020-08-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: